Management of immune thrombocytopenic purpura

Paediatrics and Child Health

Volumn 17, Issue 8, 2007, Pages 305-310

  Bolton Maggs, Paula H B ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

anti D; child; corticosteroids; haemorrhage; immune thrombocytopenia; intravenous immunoglobulin; rituximab

Indexed keywords

ANTIFIBRINOLYTIC AGENT; CORTICOSTEROID; HORMONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; RECOMBINANT THROMBOPOIETIN; RHESUS D ANTIBODY; RITUXIMAB;

ARTICLE; AUTOIMMUNE DISEASE; BLEEDING; BRAIN HEMORRHAGE; CONVALESCENCE; DISEASE REGISTRY; DRUG COST; DRUG MEGADOSE; HUMAN; INVASIVE PROCEDURE; MENORRHAGIA; PEDIATRICS; QUALITY OF LIFE; SCORING SYSTEM; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPENIC PURPURA; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

EID: 34547843605     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2007.06.003     Document Type: Article

References (35)

1. Chang M., Nakagawa P.A., Williams S.A., et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 102 (2003) 887-895
2. Kosugi S., Kurata Y., Tomiyama Y., et al. Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. Br J Haematol 93 (1996) 704-706
3. Imbach P., Kuhne T., Muller D., et al. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer 46 (2006) 351-356
4. Reid M.M. Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome. Arch Dis Child 72 (1995) 125-128
5. British Committee for Standards in Haematology. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120 (2003) 574-596
6. Bolton-Maggs P.H., and Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 350 (1997) 620-623
7. Dubansky A.S., Boyett J.M., Falletta J., et al. Isolated thrombocytopenia in children with acute lymphoblastic leukemia: a rare event in a Pediatric Oncology Group Study. Pediatrics 84 (1989) 1068-1071
8. Calpin C., Dick P., and Poon A. Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia?. Arch Pediatr Adolesc Med 152 (1998) 345-347
9. Noris P., Pecci A., Di Bari F., et al. Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. Haematologica 89 (2004) 1219-1225
10. Bowles K.M., Bloxham D.M., and Perry D.J. Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura. Br J Haematol 134 (2006) 320-322
11. Bolton-Maggs P.H., Dickerhoff R., and Vora A.J. The nontreatment of childhood ITP (or "the art of medicine consists of amusing the patient until nature cures the disease"). Semin Thromb Hemost 27 (2001) 269-275
12. Rosthoj S., Hedlund-Treutiger I., Rajantie J., et al. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort. J Pediatr 143 (2003) 302-307
13. Sutor A.H., Harms A., and Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin Thromb Hemost 27 (2001) 253-267
14. Zeller B., Rajantie J., Hedlund-Treutiger I., et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr 94 (2005) 178-184
15. Kuhne T., Buchanan G.R., Zimmerman S., et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 143 (2003) 605-608
16. Bolton-Maggs P.H.B., and Moon I. Closing the audit loop - outcome of the second national audit of the management of acute ITP - a change in practice. Blood 98 (2001) 58b
17. Lowe E.J., and Buchanan G.R. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life. J Pediatr 141 (2002) 253-258
18. Beck C.E., Nathan P.C., and Parkin P.C. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr 147 (2005) 521-527
19. Ferrara M., Borrelli B., Greco N., et al. Side effects of corticosteroid therapy in children with chronic idiopathic thrombocytopenic purpura. Hematology 10 (2005) 401-403
20. Carcao M.D., Zipursky A., and Butchart S. Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr Suppl 424 (1998) 71-74
21. Dilber C., Dagdemir A., Albayrak D., et al. Reduced bone mineral density in childhood chronic idiopathic thrombocytopenic purpura treated with high-dose methylprednisolone. Bone 35 (2004) 306-311
22. Blanchette V., Imbach P., Andrew M., et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 344 (1994) 703-707
23. Kjaersgaard M., and Hasle H. A review of anti-D treatment of childhood idiopathic thrombocytopenic purpura. Pediatr Blood Cancer 47 (2006) 717-720
24. Tarantino M.D., Young G., Bertolone S.J., et al. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. J Pediatr 148 (2006) 489-494
25. Meyer O., Kiesewetter H., Hermsen M., et al. Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia. Pediatr Blood Cancer 47 (2006) 721-722
26. Gaines A.R. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood 95 (2000) 2523-2529
27. Gaines A.R. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood 106 (2005) 1532-1537
28. Najean Y., Rain J.D., and Billotey C. The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies. Br J Haematol 97 (1997) 547-550
29. Bennett C.M., Rogers Z.R., Kinnamon D.D., et al. Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood 107 (2006) 2639-2642
30. Basser R.L., O'Flaherty E., Green M., et al. Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood 99 (2002) 2599-2602
31. Buchanan G., Kuhne T., Bolton-Maggs P., et al. Frequency, location and timing of severe hemorrhage in children with newly-diagnosed ITP: a study of the Intercontinental Childhood ITP Study Group. Blood 102 (2003) 298a
32. Buchanan G.R., and Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 141 (2002) 683-688
33. Barnard D., Woloski M., Feeny D., et al. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. J Pediatr Hematol Oncol 25 (2003) 56-62
34. Klaassen R.J., Young N.L., Barnard D., et al. The Kid's ITP Tools (KIT): validity, reliability and responsiveness of a new measure of quality of life in children with ITP. Pediatr Blood Cancer 46 (2006) 692
35. von Mackensen S., Nilsson C., Jankovic M., et al. Development of a disease-specific quality of life questionnaire for children & adolescents with idiopathic thrombocytopenic purpura (ITP-QoL). Pediatr Blood Cancer 47 (2006) 688-691